Research programme: influenza vaccines - GenVecAlternative Names: Influenza vaccines - GenVec/NIAID
Latest Information Update: 09 Sep 2013
At a glance
- Originator GenVec
- Class Viral vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Research Influenza virus infections